Finance

Lists
Why is ZLAB down 4.06%?
Dive Deeper
ZLAB:NASDAQ
Zai Lab Ltd - ADR
$21.03
-4.06%
(-0.89) 1D
$21.03
0.00% (0.00)
After hours
Closed: Nov 20, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZLAB...
Open
$20.99
High
$21.15
Low
$20.02
Mkt. cap
2.67B
Avg. vol.
1.14M
Volume
1.44M
52-wk high
$29.02
52-wk low
$15.96
EPS
-$1.78
Beta
0.77
Shares outstanding
125.83M
No. of employees
2K
Open
$20.99
High
$21.15
Low
$20.02
Mkt. cap
2.67B
Avg. vol.
1.14M
Volume
1.44M
52-wk high
$29.02
52-wk low
$15.96
EPS
-$1.78
Beta
0.77
Shares outstanding
125.83M
No. of employees
2K
News stories
From web sources and news partners
About Zai Lab Ltd - ADR
CEO-
Employees1.78K
Founded2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to ZLAB in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ZLAB in the last 3 months.
Highest
Current $21.03
$45.00 (+113.98%)
Average
$36.48 (+73.47%)
Lowest
$26.90 (+27.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Li
Bank of America Securities
Hold
Maintained
$26.90
+27.9%
11/20/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$37.00
+75.9%
11/19/2026
Li Watsek
Cantor Fitzgerald
Buy
Maintained
$37.00
+75.9%
10/25/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$45.00
+114%
10/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
127.60M
99.61M
106.31M
108.21M
Cost of goods sold
123.96M
103.93M
109.93M
101.12M
Cost of revenue
123.96M
103.93M
109.93M
101.12M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73.04M
65.07M
72.87M
70.07M
Operating expense
73.04M
65.07M
72.87M
70.07M
Total operating expenses
197.00M
169.00M
182.80M
171.19M
Operating income
-69.41M
-69.38M
-76.49M
-62.98M
Other non operating income
495.00K
162.00K
5.28M
288.00K
EBT including unusual items
-53.34M
-49.58M
-51.85M
-48.01M
EBT excluding unusual items
-53.34M
-49.58M
-51.85M
-48.01M
Income tax expense
-2.93M
1.44M
-1.02M
-1.87M
Effective tax rate
5.49%
-2.90%
1.97%
3.90%
Other operating expenses
-
-
-
-
Net income
-50.41M
-51.02M
-50.82M
-46.14M
Net profit margin
-39.51%
-51.22%
-47.81%
-42.64%
Earnings per share
-0.05
-0.05
-0.46
-0.04
Interest and investment income
7.25M
6.45M
5.88M
5.73M
Interest expense
-1.36M
-1.64M
-1.59M
-1.58M
Net interest expenses
5.89M
4.81M
4.29M
4.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
-65.49M
-65.44M
-72.32M
-58.57M
Gain or loss from assets sale
307.00K
18.00K
15.00K
15.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps